| 1036 |
|
| 1037 |
|
| 1038 |
|
| 1039 |
|
| 1040 |
|
| 1041 |
|
| 1042 |
|
| 1043 |
|
| 1044 |
|
| 1045 |
|
| 1046 |
|
| 1047 |
|
| 1048 |
|
| 1049 |
|
| 1050 |
|
| 1051 |
|
| 1052 |
|
| 1053 |
|
| 1054 |
|
| 1055 |
|
| 1056 |
|
| 1057 |
|
| 1058 |
|
| 1059 |
|
| 1060 |
|
| 1061 |
|
| 1062 |
|
| 1063 |
|
| 1064 |
|
| 1065 |
|
| 1066 |
|
| 1067 |
|
| 1068 |
|
| 1069 |
|
| 1070 |
|
| 1071 |
|
| 1072 |
Khanapur S, Paul S, Shah A, Vatakuti S, Koole MJ, Zijlma R, Dierckx RA, Luurtsema G, Garg P, van Waarde A, Elsinga PH.
Development of [18F]-labeled Pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) analogs for the imaging of Cerebral Adenosine A2A receptors with Positron Emission Tomography Journal of Medicinal Chemistry 2014,
|
| 1073 |
|
| 1074 |
|
| 1075 |
|
| 1076 |
Kulthe S, Inamdar N, Godhani C, Choudhari Y, Shirolikar S, Borde L, Thanki K, Agrawal M, Agrawal SK, Jain S, Mourya V.
Mixed Micellar Nanocarriers for Controlled and Targeted Delivery of Paclitaxel Journal of Nanopharmaceutics and Drug Delivery 2014,
|
| 1077 |
|
| 1078 |
|
| 1079 |
|
| 1080 |
|